Nuveen Asset Management’s Ventyx Biosciences VTYX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $369K | Hold |
168,420
| – | – | ﹤0.01% | 3083 |
|
|
2024
Q3 | $367K | Buy |
168,420
+34,376
| +26% | +$74.9K | ﹤0.01% | 3104 |
|
|
2024
Q2 | $310K | Hold |
134,044
| – | – | ﹤0.01% | 3144 |
|
|
2024
Q1 | $737K | Sell |
134,044
-54,703
| -29% | -$301K | ﹤0.01% | 2827 |
|
|
2023
Q4 | $466K | Sell |
188,747
-198,525
| -51% | -$490K | ﹤0.01% | 3030 |
|
|
2023
Q3 | $13.4M | Buy |
387,272
+21,158
| +6% | +$735K | ﹤0.01% | 1298 |
|
|
2023
Q2 | $12M | Buy |
366,114
+153,936
| +73% | +$5.05M | ﹤0.01% | 1386 |
|
|
2023
Q1 | $7.11M | Buy |
212,178
+19,245
| +10% | +$645K | ﹤0.01% | 1687 |
|
|
2022
Q4 | $6.33M | Buy |
192,933
+123,882
| +179% | +$4.06M | ﹤0.01% | 1783 |
|
|
2022
Q3 | $2.41M | Sell |
69,051
-432
| -0.6% | -$15.1K | ﹤0.01% | 2301 |
|
|
2022
Q2 | $850K | Buy |
69,483
+53,654
| +339% | +$656K | ﹤0.01% | 2865 |
|
|
2022
Q1 | $215K | Hold |
15,829
| – | – | ﹤0.01% | 3178 |
|
|
2021
Q4 | $314K | Buy |
+15,829
| New | +$314K | ﹤0.01% | 3171 |
|